Tubize Fin (Belgium) Executives
| TUB Stock | EUR 136.80 1.40 1.03% |
Tubize Fin employs about 12 people. The company is managed by 2 executives with a total tenure of roughly 28 years, averaging almost 14.0 years of service per executive, having 6.0 employees per reported executive. Discussion of Tubize Fin's management performance can provide insight into the enterprise performance.
| Marc Steenvoort Insider G Mang |
| Anne Pijcke Insider G Mang |
Tubize |
Tubize Fin Management Team Effectiveness
Tubize Fin's management efficiency ratios could be used to measure how well Tubize Fin manages its routine affairs as well as how well it operates its assets and liabilities.Tubize Fin Workforce Comparison
Tubize Fin is currently regarded as top stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 41,806. Tubize Fin adds roughly 12.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Tubize Fin Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Tubize Fin Price Series Summation is a cross summation of Tubize Fin price series and its benchmark/peer.
Tubize Fin Notable Stakeholders
A Tubize Fin stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Tubize Fin often face trade-offs trying to please all of them. Tubize Fin's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Tubize Fin's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Marc Steenvoort | G Mang | Profile | |
| Anne Pijcke | G Mang | Profile |
About Tubize Fin Management Performance
The success or failure of an entity such as Tubize Fin often depends on how effective the management is. Tubize Fin management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Tubize management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Tubize management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Financire de Tubize S.A., through its interest in UCB, operates as a biopharmaceutical company worldwide. The companys products in pipeline include UCB0942 for drug resistant epilepsy UCB3491 for infantile epilepsy UCB0599 for Parkinsons disease UCB7858UCB0159 for auto-inflammatory diseases UCB6673 to treat immunological diseases UCB4144VR942 to treat asthma seletalisib for treating Sjrgens syndrome dapirolizumab pegol for systemic lupus erythematosus bimekizumab to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis rozanolixizumab to treat immune thrombocytopenia and myasthenia gravis and romosozumab for post-menopausal osteoporosis and osteoporosis in men. TUBIZE FIN operates under Pharmaceuticals And Biosciences classification in Belgium and is traded on Brussels Stock Exchange.
Tubize Fin Workforce Analysis
Traditionally, organizations such as Tubize Fin use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Tubize Fin within its industry.Tubize Fin Manpower Efficiency
Return on Tubize Fin Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Income Per Employee | 31.7M | |
| Net Income Per Executive | 190M |
Additional Tools for Tubize Stock Analysis
When running Tubize Fin's price analysis, check to measure Tubize Fin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tubize Fin is operating at the current time. Most of Tubize Fin's value examination focuses on studying past and present price action to predict the probability of Tubize Fin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tubize Fin's price. Additionally, you may evaluate how the addition of Tubize Fin to your portfolios can decrease your overall portfolio volatility.